Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$1.1 - $2.17 $990,551 - $1.95 Million
-900,501 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$10.92 - $18.18 $109,200 - $181,800
10,000 Added 1.12%
900,501 $16.2 Million
Q4 2017

Feb 14, 2018

BUY
$8.48 - $12.0 $5.34 Million - $7.56 Million
630,200 Added 242.1%
890,501 $8.69 Million
Q3 2017

Nov 14, 2017

BUY
$6.38 - $8.14 $192,012 - $244,981
30,096 Added 13.07%
260,301 $2.12 Million
Q2 2017

Aug 14, 2017

BUY
N/A
230,205
230,205 $1.97 Million

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track New Leaf Venture Partners, L.L.C. Portfolio

Follow New Leaf Venture Partners, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.